PPP2CA and hepatocellular carcinoma: PP2Ac upregulation showed a poor prognostic impact on the overall survival of hepatocellular carcinoma (HCC) patients, and PP2Ac downregulation was shown to be a potential therapeutic target for HCC [18, 19].